MS
CELG.RT
Maven Securities’s Bristol-Myers Squibb Company Contingent Value Rights CELG.RT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.8K | Hold |
67,856
| – | – | ﹤0.01% | 181 |
|
|
2025
Q1 | $46.8K | Hold |
67,856
| – | – | ﹤0.01% | 266 |
|
|
2024
Q4 | $46.8K | Buy |
+67,856
| New | +$46.8K | ﹤0.01% | 289 |
|
|
2023
Q4 | – | Sell |
-67,856
| Closed | -$46.8K | – | 273 |
|
|
2023
Q3 | $46.8K | Hold |
67,856
| – | – | ﹤0.01% | 270 |
|
|
2023
Q2 | $46.8K | Hold |
67,856
| – | – | ﹤0.01% | 243 |
|
|
2023
Q1 | $46.8K | Hold |
67,856
| – | – | ﹤0.01% | 194 |
|
|
2022
Q4 | $46.8K | Hold |
67,856
| – | – | ﹤0.01% | 201 |
|
|
2022
Q3 | $47K | Hold |
67,856
| – | – | ﹤0.01% | 404 |
|
|
2022
Q2 | $47K | Hold |
67,856
| – | – | ﹤0.01% | 317 |
|
|
2022
Q1 | $47K | Hold |
67,856
| – | – | ﹤0.01% | 315 |
|
|
2021
Q4 | $47K | Buy |
+67,856
| New | +$47K | ﹤0.01% | 338 |
|
|
2021
Q3 | – | Sell |
-67,856
| Closed | -$47K | – | 555 |
|
|
2021
Q2 | $47K | Buy |
+67,856
| New | +$47K | ﹤0.01% | 577 |
|